Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19

Synthetic glucocorticoid dexamethasone is the first trial-proven drug that reduces COVID-19 mortality by suppressing immune system. In contrast, interferons are a crucial component of host antiviral immunity and can be directly suppressed by glucocorticoids. To investigate whether therapeutic interf...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yingying, Liu, Feng, Tong, Gangling, Qiu, Feng, Song, Pinhong, Wang, Xiaolin, Zou, Xiafei, Wan, Deyun, Cui, Miao, Xu, Yunsheng, Zheng, Zhihua, Hong, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925812/
https://www.ncbi.nlm.nih.gov/pubmed/33658482
http://dx.doi.org/10.1038/s41392-021-00496-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925812/
https://www.ncbi.nlm.nih.gov/pubmed/33658482
http://dx.doi.org/10.1038/s41392-021-00496-5

Ejemplares similares